We chose anti-Bcl-xl siRNA since this anti-apoptotic protein is frequently overexpressed in many tumors and plays a crucial role in cancer progression [30], making it a good target for gene therapy [31,32]. The gene discussed is BCL2L1; the disease is cancer.